Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
Milestone Scientific, Inc. (MLSS)
NASDAQ:AMEX Investor Relations:
ir.milestonescientific.com
Company Research
Source: GlobeNewswire
Reports 57% increase in international dental sales for the third quarter of 2024 Advances commercial rollout of CompuFlo® Epidural System across additional pain management clinics following Medicare price assignment in multiple U.S. states ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported financial results for the third quarter ended September 30, 2024. Arjan Haverhals, CEO of Milestone Scientific, commented, “We are pleased to report a 22% year-over-year increase in total revenue, reaching $2.5 million for the third quarter of 2024. This growth was primarily driven by robust performance in our dental segment, where international dental sales rose by an impressive 57%, supported by strong demand in the domestic market. Our focus on expanding global distribution and leveraging our e-commerce platform c
Show less
Read more
Impact Snapshot
Event Time:
MLSS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MLSS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MLSS alerts
High impacting Milestone Scientific, Inc. news events
Weekly update
A roundup of the hottest topics
MLSS
News
- Milestone Scientific Inc. (NYSE: MLSS) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $1.25 price target on the stock.MarketBeat
- Milestone Scientific Inc. (NYSE: MLSS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Milestone Scientific Inc (MLSS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]Yahoo! Finance
- Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024 [Yahoo! Finance]Yahoo! Finance
MLSS
Sec Filings
- 11/14/24 - Form 10-Q
- 11/14/24 - Form 8-K
- 10/23/24 - Form 4
- MLSS's page on the SEC website